Yvonne K. Franzese, serving as Chief Human Resources Officer at CNO Financial Group (NASDAQ: CNO), completed the sale of 9,000 shares of the company's common stock on February 17, 2026. The disposition took place in three equal tranches of 3,000 shares each and produced total proceeds of $388,556.
The three blocks were transacted at closely aligned weighted average prices. The first block of 3,000 shares carried a weighted average price of $43.1638, with executed prices in that tranche ranging from $42.94 to $43.79. The second block of 3,000 shares reported a weighted average price of $43.1807, with individual execution prices between $43.00 and $43.79. The third 3,000-share block had a weighted average price of $43.1744, and trades in that group ranged from $42.94 to $43.73.
Following these sales, Franzese's reported direct ownership stands at 35,062 shares of CNO Financial Group common stock. She also indirectly holds 78,279 shares through the Yvonne K. Franzese Revocable Trust. The sales were carried out pursuant to a Rule 10b5-1 trading plan that Franzese adopted on August 20, 2025.
In related corporate disclosures, CNO Financial Group released its fourth-quarter 2025 financial results. The insurer reported earnings per share of $0.95, short of the $1.21 that had been anticipated. Revenue for the quarter totaled $1.14 billion, exceeding the $1.00 billion estimate.
These results present a mixed picture: a revenue beat paired with an EPS miss. The company has not reported any notable analyst upgrades or downgrades tied to the quarterly release, nor have there been recent announcements regarding mergers or other significant corporate actions. Observers of the company may weigh the stronger-than-expected top line against the profit shortfall when assessing the quarter.
No additional transactions, corporate developments, or analyst movements related to CNO Financial Group were disclosed in connection with these items.
Summary of key facts
- Insider sales: 9,000 shares sold on February 17, 2026 in three tranches of 3,000 shares each.
- Proceeds: $388,556 from the transactions executed at weighted average prices between $43.1638 and $43.1807.
- Current holdings: 35,062 shares directly and 78,279 shares indirectly via a revocable trust.
- Trading plan: Sales conducted under a Rule 10b5-1 plan adopted August 20, 2025.
- Quarterly results: Q4 2025 EPS of $0.95 (vs. $1.21 expected) and revenue of $1.14 billion (vs. $1.00 billion expected).